echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Just this Saturday! The release of the "Guidelines for the Diagnosis and Treatment of Primary Osteoporosis 2022 Edition" is here

    Just this Saturday! The release of the "Guidelines for the Diagnosis and Treatment of Primary Osteoporosis 2022 Edition" is here

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    *For medical professionals only, new

    guidelines are released!





    In order to improve the understanding of medical staff on the diagnosis and treatment norms of primary osteoporosis, the Osteoporosis and Bone Mineral Diseases Branch of the Chinese Medical Association will hold the "Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022 Edition) Release Conference"
    in Shanghai, Beijing and Changsha on December 31, 2022.


    In order to bring you the latest and hottest guide reports, the "Medical Endocrinology Channel" will participate in the conference offline and broadcast it synchronously, please click the live appointment button below (or scan the corresponding content two-dimensional code), and enjoy the academic feast together~


    Doctor Station APP to watch the QR code, the web version of the doctor station is online,
    please scan the QR code below or click to read the


    original article No need to download to view more endocrine frontiers


    Responsible editorTangerine



    Call for Papers The Medical Endocrinology Channel welcomes your submissions! Click the link below or scan the QR code to submit: https://titan.
    yishengzhan.
    cn/#/public_contribution
    Please fill in the real information according to the call page*"The medical community" strives to publish the content professional and reliable, but does not promise the accuracy of the content; Relevant parties are requested to check
    separately when adopting or using it as a basis for decision-making.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.